Background: Parkinson’s disease is a common, age-related progressive neurodegenerative disorder with considerable socioeconomic burdens, although the studies in incremental burdens to the disease’s rapid growth are incomplete and lag behind. We aim to assess global burdens of Parkinson’s disease based on a public database online. Methods: Based on the Global Burden of Disease, Injuries, and Risk Factors Study, we screened a range of indicators including prevalence cases, disability-adjusted life-years (DALYs), age-standardized prevalence rates (ASPRs), and age-standardized DALY rate (ASDR). The join point regression was used to assess the indicators, wherein the ASPR and the ASDR were referred to temporal trends for burdens of Parkinson’s disease. Results: Prevalence cases of global Parkinson’s disease were on the rise for 30 years, with an increase of 155.51% during 1990–2019. Temporal trend of ASDRs was on the rise during 1990–2002 but in decline during 2002–2019. The ASPRs had a turning point in 2017 and a decline during 2017–2019 (annual percentage change = −0.51%, p > 0.05). China, India, the USA, Japan, and Germany shared the five highest prevalence cases and DALYs in 2019. The Socio-Demographic Index (SDI) was in relation to a significantly positive ASPR (R = 0.61, p < 0.001) but not a significantly negative ASDR (R = −0.044, p = 0.53), respectively. Conclusions: In this study, a range of indicators for global burdens of Parkinson’s disease were on the rise during 1990–2019. Tremendous efforts should be in place to prevent Parkinson’s disease, especially among the populations of males, with advanced ages, in East Asia, and in regions with high SDI.

1.
Feigin
VL
,
Nichols
E
,
Alam
T
,
Bannick
MS
,
Beghi
E
,
Blake
N
,
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
.
Lancet Neurol
.
2019
;
18
(
5
):
459
80
.
2.
Parkinson
J
.
An essay on the shaking palsy. 1817
.
J Neuropsychiatry Clin Neurosci
.
2002
;
14
(
2
):
223
2
; discussion 222. .
3.
Tysnes
OB
,
Storstein
A
.
Epidemiology of Parkinson’s disease
.
J Neural Transm
.
2017 Aug
;
124
(
8
):
901
5
. .
4.
Garcia-Ptacek
S
,
Kramberger
MG
.
Parkinson disease and dementia
.
J Geriatr Psychiatry Neurol
.
2016 Sep
;
29
(
5
):
261
70
. .
5.
Potashkin
J
,
Huang
X
,
Becker
C
,
Chen
H
,
Foltynie
T
,
Marras
C
.
Understanding the links between cardiovascular disease and Parkinson’s disease
.
Mov Disord
.
2020 Jan
;
35
(
1
):
55
74
. .
6.
Delamarre
A
,
Meissner
WG
.
Epidemiology, environmental risk factors and genetics of Parkinson’s disease
.
Presse Med
.
2017 Mar
;
46
(
2 Pt 1
):
175
81
. .
7.
GBD 2016 Parkinson’s Disease Collaborators
.
Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
.
Lancet Neurol
.
2018 Nov
;
17
(
11
):
939
53
. .
8.
Bloem
BR
,
Okun
MS
,
Klein
C
.
Parkinson’s disease
.
Lancet
.
2021
;
397
(
10291
):
2284
303
. .
9.
Lee
GB
,
Woo
H
,
Lee
SY
,
Cheon
SM
,
Kim
JW
.
The burden of care and the understanding of disease in Parkinson’s disease
.
PLoS One
.
2019
;
14
(
5
):
e0217581
. .
10.
Stevens
GA
,
Alkema
L
,
Black
RE
,
Boerma
JT
,
Collins
GS
,
Ezzati
M
,
Guidelines for accurate and transparent health estimates reporting: the GATHER statement
.
Lancet
.
2016
;
388
(
10062
):
e19
23
.
11.
Vos
T
,
Lim
SS
,
Abbafati
C
,
Abbas
KM
,
Abbasi
M
,
Abbasifard
M
,
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
.
Lancet
.
2020
;
396
(
10258
):
1204
22
.
12.
Global Burden of Disease Collaborative Network
.
Global Burden of Disease Study 2019 (GBD 2019) cause list mapped to ICD codes
.
2020
. Seattle, USA: Institute for Health Metrics and Evaluation (IHME) [cited 2021 Dec 25]. Available from: http://ghdx.healthdata.org/record/ihme-data/gbd-2019-cause-icd-code-mappings.
13.
He
H
,
Hu
C
,
Ren
Z
,
Bai
L
,
Gao
F
,
Lyu
J
.
Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: results from the Global Burden of Disease Study 2017
.
J Psychiatr Res
.
2020 Jun
;
125
:
96
105
. .
14.
Mehanna
R
,
Moore
S
,
Hou
JG
,
Sarwar
AI
,
Lai
EC
.
Comparing clinical features of young onset, middle onset and late onset Parkinson’s disease
.
Parkinsonism Relat Disord
.
2014 May
;
20
(
5
):
530
4
. .
15.
Wu
Y
,
Fu
R
,
Lei
C
,
Deng
Y
,
Lou
W
,
Wang
L
,
Estimates of type 2 diabetes mellitus burden attributable to particulate matter pollution and its 30-year change patterns: a systematic analysis of data from the Global Burden of Disease Study 2019
.
Front Endocrinol
.
2021
;
12
:
689079
.
16.
Prado
M
 Jr
,
Jamora
RD
.
Cost of Parkinson’s disease among Filipino patients seen at a public tertiary hospital in Metro Manila
.
J Clin Neurosci
.
2020 Apr
;
74
:
41
6
. .
17.
Martinez-Martin
P
,
Macaulay
D
,
Jalundhwala
YJ
,
Mu
F
,
Ohashi
E
,
Marshall
T
,
The long-term direct and indirect economic burden among Parkinson’s disease caregivers in the United States
.
Mov Disord
.
2019 Feb
;
34
(
2
):
236
45
.
18.
Collier
TJ
,
Kanaan
NM
,
Kordower
JH
.
Aging and Parkinson’s disease: different sides of the same coin?
Mov Disord
.
2017 Jul
;
32
(
7
):
983
90
. .
19.
Vila
M
.
Neuromelanin, aging, and neuronal vulnerability in Parkinson’s disease
.
Mov Disord
.
2019 Oct
;
34
(
10
):
1440
51
. .
20.
Gillies
GE
,
Pienaar
IS
,
Vohra
S
,
Qamhawi
Z
.
Sex differences in Parkinson’s disease
.
Front Neuroendocrinol
.
2014 Aug
;
35
(
3
):
370
84
. .
21.
Jurado-Coronel
JC
,
Cabezas
R
,
Ávila Rodríguez
MF
,
Echeverria
V
,
García-Segura
LM
,
Barreto
GE
.
Sex differences in Parkinson’s disease: features on clinical symptoms, treatment outcome, sexual hormones and genetics
.
Front Neuroendocrinol
.
2018 Jul
;
50
:
18
30
. .
22.
Cerri
S
,
Mus
L
,
Blandini
F
.
Parkinson’s disease in women and men: what’s the difference?
J Parkinsons Dis
.
2019
;
9
(
3
):
501
15
. .
23.
Iwaki
H
,
Blauwendraat
C
,
Leonard
HL
,
Makarious
MB
,
Kim
JJ
,
Liu
G
,
Differences in the presentation and progression of Parkinson’s disease by sex
.
Mov Disord
.
2021 Jan
;
36
(
1
):
106
17
.
24.
Hu
CY
,
Fang
Y
,
Li
FL
,
Dong
B
,
Hua
XG
,
Jiang
W
,
Association between ambient air pollution and Parkinson’s disease: systematic review and meta-analysis
.
Environ Res
.
2019 Jan
;
168
:
448
59
.
25.
National Bureau of Statistics of China
.
Communiqué of the seventh national population census (No. 2)
.
2021
[cited 2021 Dec 25]. Available from: http://www.stats.gov.cn/english/PressRelease/202105/t20210510_1817187.html.
26.
United Nations, Department of Economic and Social Affairs, Population Division
.
World population prospects 2019: highlights
.
2019
[cited 2021 Dec 25]. Available from: https://population.un.org/wpp/Publications/Files/WPP2019_Highlights.pdf.
27.
Statistical Bureau of Japan
.
Current population estimates as of October 1, 2019
.
2019
[cited 2021 Dec 25]. Available from: https://www.stat.go.jp/english/data/jinsui/2019np/index.html.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.